NCT04055142View on ClinicalTrials.gov

Clinical Trial for Evaluating the Efficacy and Safety of Electrocoagulation vs Topic Sinecatechins vs Topic Cidofovir Within the Treatment to High-grade Anal Intraepithelial Neoplasia in HIV Homosexual Males

PHASE3CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

September 18, 2020

Primary Completion Date

January 11, 2024

Study Completion Date

July 2, 2024

Conditions
High-grade Anal Intraepithelial Neoplasia
Interventions
PROCEDURE

electrocoagulation

HIV homosexuals males with High-grade anal intraepithelial neoplasia will be randomized and electrocoagulation will be performed in 2-3 sessions (session every 2 weeks)

DRUG

cidofovir 1% topical ointment

HIV homosexuals males with High-grade anal intraepithelial neoplasia will be randomized and they will be treated with cidofovir 1% ointment (3 times per week during 8 weeks)

DRUG

sinecatechins 10% topical ointment

HIV homosexuals males with High-grade anal intraepithelial neoplasia will be randomized and they will be treated with sinecatechins 10% ointment (3 times per week during 8 weeks)

Trial Locations (1)

08035

Hospital U. Vall d'Hebrón, Barcelona

All Listed Sponsors
lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER

NCT04055142 - Clinical Trial for Evaluating the Efficacy and Safety of Electrocoagulation vs Topic Sinecatechins vs Topic Cidofovir Within the Treatment to High-grade Anal Intraepithelial Neoplasia in HIV Homosexual Males | Biotech Hunter | Biotech Hunter